Search Browse Earnings

ALPINE IMMUNE SCIENCES, INC.

Pharmaceutical Preparations·SEATTLE, WA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

ALPINE IMMUNE SCIENCES, INC. — SlamSEC

Revenue

$23.4M

+151.1% YoY

FY 2023

Adj. EBITDA

-$49.2M

-210.0% margin

FY 2023

Net Income

-$50.3M

-214.7% margin

FY 2023

EPS (Diluted)

-$1.98

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$13.4M

FY 2023

Total Debt

$3.4M

FY 2022

Net Cash

$10.0M

FY 2022

Enterprise Value

—

Debt / EBITDA

0.2x

FY 2023

EV / EBITDA

—

Employees

—